Replies to post #888 on Javelin Pharmaceuticals Inc (JAV)

[rstor1]

Gabe,

A lot depends on what you choose to call successful. At $3/share, any financing will be quite dilutive and will usually require sweetners.

Google Rodman & Renshaw. They specialize in micro-cap bios and I'm sure they have handle a number of them sub-$5.

Bob

[apljack]

Gabe, you're kidding, right? Take a look at Peregrine pharmaceuticls (PPHM). They've remained alive for years by offering more and more stock on the open market for decreasing share value for years. I've watched their outstanding share count run from under 100 million to 225 million+ range at present.

It appears that someone will always risk some capital when there are prospects of a winning drug. Given the relative strength of JAV's product line (with 1 of 3 products on the market and 3 of 3 candidates likely to reach the market), I think that there will be plenty of interest in any shelf registration.

BTW, if there are hard ball playing institutions working to pick up shares on the cheap (and it appears there are such entities working here) don't you think that they are having a good laugh at their ability to shake you loose of 120K shares after you blab on this board about your dissatisfaction?

aj